Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20455246 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Condition: Generalized Anxiety Disorder
Interventions: Drug: pexacerfont;   Drug: escitalopram;   Drug: placebo

Indicates status has not been verified in more than two years